Definitive Healthcare (DH) Common Equity (2020 - 2026)

Definitive Healthcare has reported Common Equity for 7 years, with the latest figure at $190.7 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity fell 56.25% year-over-year to $190.7 million; the trailing twelve-month figure through Mar 2026 stood at $190.7 million (down 56.25% YoY), and the FY2025 full-year result was $379.0 million, down 37.58% from the prior year.
• Common Equity for Q1 2026 stood at $190.7 million, down from $379.0 million in the prior quarter.
• The five-year high for Common Equity was $1.5 billion in Q1 2022, with the low at $190.7 million in Q1 2026.
• Historically, Common Equity has averaged $967.4 million across 5 years, with a median of $1.2 billion in 2024.
• Annual changes were most pronounced in 2022 — Common Equity rose 26.76% — and 2025, when it tumbled 63.52%.
• Definitive Healthcare's Common Equity stood at $1.5 billion in 2022, then fell by 19.08% to $1.2 billion in 2023, then slumped by 49.37% to $607.2 million in 2024, then plunged by 37.58% to $379.0 million in 2025, then sank by 49.68% to $190.7 million in 2026.
• The last three Common Equity figures came in at $190.7 million (Q1 2026), $379.0 million (Q4 2025), and $389.7 million (Q3 2025), per Business Quant data.